Daniel Ben-Mordechay: Portal Vein Thrombosis – Ultrasound Perspective
Daniel Ben-Mordechay, Chief Executive Officer at Orimed GTD, shared a post on LinkedIn:
“Portal Vein Thrombosis (PVT): Ultrasound Perspective
Portal vein thrombosis is a key cause of prehepatic portal hypertension, resulting from partial or complete obstruction of the portal vein lumen by thrombus formation.
Clinically, PVT may be asymptomatic, particularly in chronic settings, and is often detected incidentally during imaging follow-up in patients with underlying liver disease.
However, in acute cases, it may present with abdominal pain or signs related to mesenteric venous involvement.
From an imaging standpoint, multiple modalities can be used for diagnosis and characterization, including CT and MRI.
Nevertheless, ultrasound remains the first-line imaging modality due to its availability, safety, and real-time assessment capabilities.
Ultrasound findings:
- Gray-scale imaging
Acute PVT typically appears as echogenic or heterogeneous material within the portal vein lumen. The vein may appear distended compared to normal, especially in early stages.
- Color Doppler evaluation
The hallmark finding is partial or complete absence of flow within the portal vein. In some cases, reduced or altered flow patterns may be observed rather than complete absence.
- Chronic PVT considerations
In longstanding cases, cavernous transformation may develop, characterized by multiple serpiginous collateral vessels replacing the normal portal vein.
From a POCUS perspective, recognizing the combination of intraluminal material and absent or abnormal Doppler flow is critical for raising suspicion and prompting further evaluation.
Early identification has direct clinical implications, particularly in guiding anticoagulation, evaluating underlying etiologies, and preventing complications such as portal hypertension and bowel ischemia.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 02:06Giovanni Merlino: Scientific Progress in Secondary Stroke Prevention at Udine Stroke Congress 2026
-
Jun 26, 2026, 01:48Michael Stark: Highlights from ISBT 2026 on RBC Transfusion and NEC in Neonates
-
Jun 25, 2026, 23:08Geert Verheyden: Belgium’s Vision for Better Stroke Care Across the Continuum
-
Jun 25, 2026, 21:04Else Charlotte Sandset: Pleasure to Welcome Polish Delegation to Oslo University Hospital Stroke Tour
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026